Synergism between biocides and antibiotics was investigated in 20 biocide and antibiotic-resistant bacterial strains that were previously isolated from organically produced foods, according to their antimicrobial resistance profiles. Most of the antibiotic/biocide combinations yielded synergistic interactions, reducing the inhibitory concentrations of biocides and antibiotics by 4- to 16-fold. Among enterococci, synergism with biocides was detected for amoxicillin (AM), cefuroxime (CX), erythromycin (EM), ciprofloxacin (CP), and trimethoprim/sulphametoxazol (T/S). Among staphylococci, interactions were synergistic (AM) and either synergistic or indifferent (CX and EM, depending on biocide). Among the three methicillin-resistant Staphylococcus aureus clinical strains included in the study, the combinations of methicillin and triclosan or hexachlorophene acted synergistically in all strains, but interactions were either synergistic or indifferent for the other biocides, depending on the strain. All combinations tested were synergistic for Lactobacillus (AM, CX, EM, and CP) and Micrococcus (AM, EM). In Salmonella, interactions were indifferent (AM, CX, EM, and CP) or synergistic (T/S). Synergism with biocides was also detected in Klebsiella isolates (AM, CX, and T/S), Enterobacter sp. (AM, CX, EM, and T/S), Pantoea (AM, CX, EM, CP, and T/S), and Chryseobacterium sp. (EM). These results suggest that combinations of biocides and antibiotics may open new possibilities to combat antimicrobial resistance.
Get full access to this article
View all access options for this article.
References
1.
BoothH.W.1998. Antiseptics and disinfectants. Clin. Pharmacol. Ther., 28:233–248.
2.
BotelhoM.G.2000. Fractional inhibitory concentration index of combinations of antibacterial agents against cariogenic organisms. J. Dent., 28:565–570.
3.
BradyL.M., ThomsonM., PalmerM.A., and HarknessJ.L.1990. Successful control of endemic MRSA in a cardiothoracic surgical unit. Med. J. Aust., 152:240–245.
4.
CoiaJ.E., DuckworthG.J., EdwardsD.I., FarringtonM., FryC., HumphreysH., MallaghanC., and TuckerD.R.. 2006. Joint Working Party of the British Society of Antimicrobial Chemotherapy; Hospital Infection Society; Infection Control Nurses Association. “Guidelines for the control and prevention of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities”. J. Hosp. Infect., 63:S1–S44.
5.
ComengeY., QuintilianiR.Jr., LiL., DubostL., BrouardJ.P., HugonnetJ.E., and ArthurM.. 2003. The CroRS two-component regulatory system is required for intrinsic beta-lactam resistance in Enterococcus faecalis. J. Bacteriol., 185:7184–7192.
6.
DenyerS.P., HugoW.B., and HardingV.D.. 1986. The biochemical basis of synergy between the antibacterial agents, chlorocresol and 2-phenylethanol. Int. J. Pharm., 29:29–36.
7.
DibnerJ.J., and RichardsJ.D.. 2005. Antibiotic growth promoters in agriculture: history and mode of action. Poult. Sci., 84:634–643.
8.
EdmistonC.E.Jr., BrudenB., RucinskiM.C., HenenC., GrahamM.B., and LewisB.L.. 2013. Reducing the risk of surgical site infections: does chlorhexidine gluconate provide a risk reduction benefit?. Am. J. Infect. Control, 41:S49–S55.
9.
Fernández-FuentesM.A., Ortega MorenteE., AbriouelH., Pérez-PulidoR., and GálvezA.. 2012. Isolation and identification of bacteria from organic foods: Sensitivity to biocides and antibiotics. Food Cont., 26:73–78.
10.
FudaC.C., FisherJ.F., and MobasheryS.. 2005. Beta-lactam resistance in Staphylococcus aureus: the adaptive resistance of a plastic genome. Cell. Mol. Life Sci., 62:2617–2633.
11.
GilberP., and MooreL.E.2005. Cationic antiseptics: diversity of action under a common epithet. J. Appl. Microbiol., 99:703–715.
12.
GuillenJ., BernabeuA., ShapiroS., and VillalainJ.2004. Location and orientation of triclosan in phospholipid model membranes. Eur. Biophys. J., 33:448–453.
13.
GuoN., WuX., YuL., LiuJ., MengR., JinJ., LuH., WangX., YanS., and DengX.2009. In vitro and in vivo interactions between fluconazole and allicin against clinical isolates of fluconazole resistant Candida albicans determined by alternative methods. FEMS Immunol. Med. Microbiol., 58:193–201.
14.
HendryE.R., WorthingtonT., ConwayB.R., and LambertP.A.. 2009. Antimicrobial efficacy of eucalyptus oil and 1,8-cineole alone and in combination with chlorhexidine digluconate against microorganisms grown in planktonic and biofilm cultures. J. Antimicrob, Chemother., 64:1219–1225.
15.
HeuerH., SchmittH., and SmallaK.2011. Antibiotic resistance gene spread due to manure application on agricultural fields. Curr. Opin. Microbiol., 14:236–243.
16.
IoannouC.J., HanlonG.W., and DenyerS.P.. 2007. Action of disinfectant quaternary ammonium compounds against Staphylococcus aureus. Antimicrob. Agents Chemother., 51:296–306.
17.
KarkiS., and ChengA.C.2012. Impact of non-rinse skin cleansing with chlorhexidine gluconate on prevention of healthcare-associated infections and colonization with multi-resistant organisms: a systematic review. J. Hosp. Infect., 82:71–84.
18.
KarpanenT.J., WorthingtonT., HendryE.R., ConwayB.R., and LambertP.A.. 2008. Antimicrobial efficacy of chlorhexidine digluconate alone and in combination with eucalyptus oil, tea tree oil and thymol against planktonic and biofilm cultures of Staphylococcus epidermidis. J. Antimicrob. Chemother., 62:1031–1036.
19.
KolumanA., and DikiciA.2013. Antimicrobial resistance of emerging foodborne pathogens: status quo and global trends. Crit. Rev. Microbiol., 39:57–69.
20.
KristichC.J., LittleJ.L., HallC.L., and HoffJ.S.. 2011. Reciprocal regulation of cephalosporin resistance in Enterococcus faecalis. mBio, 2:e00199–e00111.
21.
LandersT.F., CohenB., WittumT.E., and LarsonE.L.. 2012. A review of antibiotic use in food animals: perspective, policy, and potential. Public Health Rep., 127:4–22.
22.
LeeE.W., HudaM.N., KurodaT., MizushimaT., and TsuchiyaT.. 2003. EfrAB, an ABC multidrug efflux pump in Enterococcus faecalis. Antimicrob. Agents Chemother., 47:3733–3738.
23.
LubelskiJ., KoningsW.M., and DriessenA.J.2007. Distribution and physiology of ABC-type transporters contributing to multidrug resistance in bacteria. Microbiol. Mol. Biol. Rev., 71:463–476.
MarshallB.M., and LevyS.B.. 2011. Food animals and antimicrobials: impacts on human health. Clin. Microbiol. Rev., 24:718–733.
26.
McDonnellG., and RussellA.D.1999. Antiseptics and disinfectants: activity, action and resistance. Clin. Microbiol. Rev., 12:147–179.
27.
McMurryL.M., OethingerM., and LevyS.B.. 1998. Overexpression of marA, soxS, or acrAB produces resistance to triclosan in laboratory and clinical strains of Escherichia coli. FEMS Microbiol. Lett., 166:305–309.
28.
MerianosJ.J.1991. Quaternary ammonium compounds. In BlockS.S. (ed.), Disinfection, Sterilization and Preservation, third edition. Lea & Febiger, Philadelphia, pp. 225–255.
29.
National Mastitis Council. 2009. Summary of peer-reviewed publications on efficacy of premilking and postmilking teat disinfectants published since 1980. Verona: National Mastitis Council, pp. 213–227.
30.
PooleK.2005. Efflux-mediated antimicrobial resistance. J. Antimicrob. Chemother., 56:20–51.
31.
PooleK. 2007. Efflux pumps as antimicrobial resistance mechanisms. Ann. Med., 39:162–176.
32.
RukayadiY., LeeK., LeeM.S., YongD., and HwangJ.K.. 2009. Synergistic anticandidal activity of xanthorrhizol in combination with ketoconazole or amphotericin B. FEMS Yeast Res., 9:1302–1311.
33.
RussellA.D.2004. Whither triclosan?. J. Antimicrob. Chemother., 53:693–695.
SchweizerH.P.2001. Triclosan: a widely used biocide and its link to antibiotics. FEMS Microbiol. Lett., 202:1–7.
36.
SchweizerH.P.2003. Efflux as a mechanism of resistance to antimicrobials in Pseudomonas aeruginosa and related bacteria: unanswered questions. Genet. Mol. Res., 2:48–62.
37.
SpoorL.E., McAdamP.R., WeinertL.A., RambautA., HasmanH., AarestrupF.M., KearnsA.M., LarsenA.R., SkovR.L., and FitzgeraldJ.R.. 2013. Livestock origin for a human pandemic clone of community-associated methicillin-resistant Staphylococcus aureus. mBio, 4:e00356–e00313.
38.
TabakM., ScherK., ChikindasM.L., and YaronS.. 2009. The synergistic activity of triclosan and ciprofloxacin on biofilms of Salmonella Typhimurium. FEMS Microbiol. Lett., 301:69–76.
39.
UbukataK., YamashitaN., and KonnoM.1985. Occurrence of a β-lactam-inducible penicillin-binding protein in methicillin-resistant staphylococci. Antimicrob. Agents Chemother., 27:851–857.
40.
van LooI., HuijsdensX., TiemersmaE., de NeelingA., van de Sande-BruinsmaN., BeaujeanD., VossA., and KluytmansJ.2007. Emergence of methicillin-resistant Staphylococcus aureus of animal origin in humans. Emerg. Infect. Dis., 13:1834–1839.
41.
VerraesC., Van BoxstaelS., Van MeervenneE., Van CoillieE., ButayeP., CatryB., de SchaetzenM.A., Van HuffelX., ImberechtsH., DierickK., DaubeG., SaegermanC., De BlockJ., DewulfJ., and HermanL.. 2013. Antimicrobial resistance in the food chain: a review. Int. J. Environ. Res. Public Health, 10:2643–2669.
42.
VillalainJ., MateoC.R., ArandaF.J., ShapiroS., and MicolV.. 2001. Membranotropic effects of the antibacterial agent triclosan. Arch. Biochem. Biophys., 390:128–136.
43.
WebberM.A., RandallL.P., CoolesS., WoodwardM.J., and PiddockL.J.. 2008. Triclosan resistance in Salmonella enterica serovar Typhimurium. J. Antimicrob. Chemother., 62:83–91.
44.
WignallG.R., GoneauL.W., ChewB.H., DenstedtJ.D., and CadieuxP.A.. 2008. The Effects of triclosan on uropathogen susceptibility to clinically relevant antibiotics. J. Endourol., 22:2349–2356.
45.
ZafarA.B., ButlerR.C., ReeseD.J., GaydosL.A., and MennonnaP.A.. 1995. Use of 0.3% triclosan (Bacti-Stat) to eradicate an outbreak of methicillin-resistant Staphylococcus aureus in a neonatal nursery. Am. J. Infect. Control, 23:200–208.
46.
ZengX., and LinJ.2013. Beta-lactamase induction and cell wall metabolism in Gram-negative bacteria. Front Microbiol., 4:128.
47.
ZhaoY., VermaV., BelchevaA., SinghA., FridmanM., and Golemi-KotraD.2012. Staphylococcus aureus methicillin-resistance factor fmtA is regulated by the global regulator SarA. PLoS One, 7:e43998.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
